Status:
RECRUITING
Hong Kong Spinocerebellar Ataxias Registry
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Spinocerebellar Ataxia
Eligibility:
All Genders
18-90 years
Brief Summary
Spinocerebellar ataxias (SCA) 1, 2, 3 and 6 are the most common, autosomal dominantly inherited cerebellar degenerations. And in the Chinese population, the most common SCA is SCA3 and the frequency o...
Detailed Description
All the members from Hong Kong SCA association will be invited and discuss the study with them. After obtaining the informed consent, their genotypes will be determined and collect clinical informatio...
Eligibility Criteria
Inclusion
- Age 18 years and above
- Presence of symptoms and signs of ataxia
- Definite molecular diagnosis of SCA1, 2, 3, 6, 7, 8 or 12 either in the participant or another affected family member
- Willingness to participate in the study and ability to give informed consent
Exclusion
- 1\. Known recessive. X-linked, and mitochondrial ataxias
Key Trial Info
Start Date :
December 7 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2034
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03336008
Start Date
December 7 2012
End Date
December 31 2034
Last Update
August 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Hong Kong, Shatin, Hong Kong, 000